Analgesic Efficacy of External Oblique Intercostal Block vs Subcostal Transversus Abdominis Plane Block in Open Surgical Nephrectomy
Launched by CAIRO UNIVERSITY · Sep 2, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief for cancer patients undergoing open nephrectomy, which is a surgery to remove a kidney. The researchers want to find out which method works better: one that targets a specific area in the abdomen using ultrasound guidance (the external oblique intercostal block) or another that focuses on a different area of the abdomen (the subcostal transversus abdominis plane block). The goal is to see how effective each technique is in managing pain during and after the surgery.
To participate in this trial, patients need to be between 18 and 65 years old and have a cancer diagnosis that requires them to have an open nephrectomy. They should be in good overall health according to the American Society of Anesthesiologists (ASA) classification, which assesses a patient's physical status. However, patients with certain conditions, such as severe obesity, cognitive disorders, or those who have allergies to the medications used, won't be eligible. Participants can expect to receive one of the two pain relief methods during their surgery and will be monitored for their pain levels afterward. The trial is currently recruiting participants to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age (18-65) year.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) class II and III.
- • Cancer patients candidate for open nephrectomy .
- Exclusion Criteria:
- • Patient refusal.
- • Skin lesions or infection at the site of proposed needle insertion.
- • Cognitive disorders.
- • History of psychiatric disorders or drug abuse.
- • Patients allergic to medication used.
- • ASA class IV.
- • Coagulopathy.
- • Body mass index (BMI) more than 35.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported